Living donor liver transplantation and hepatitis C

Romanian Journal of Gastroenterology

Volumn 13, Issue 4, 2004, Pages 317-327

  Gheorghe, Liana ^a   Iacob, Speranţa ^a   Popescu, Irinel ^a  

^a FUNDENI CLINICAL INSTITUTE   (Romania)

Author keywords

Living donor liver transplantation; Prevention; Viral C hepatitis

Indexed keywords

CORTICOSTEROID; GRANULOCYTE COLONY STIMULATING FACTOR; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INTERFERON; LOW DENSITY LIPOPROTEIN RECEPTOR; OKT 3; PEGINTERFERON; RECOMBINANT ERYTHROPOIETIN; RIBAVIRIN; VIRUS RNA;

CYTOMEGALOVIRUS INFECTION; DEMOGRAPHY; GRAFT INFECTION; GRAFT REJECTION; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HLA MATCHING; HUMAN; LIVER BIOPSY; LIVER FAILURE; LIVER FIBROSIS; LIVER REGENERATION; LIVER TRANSPLANTATION; LIVING DONOR; MORTALITY; PATIENT SELECTION; RECURRENT VIRUS INFECTION; REVIEW; RISK FACTOR;

HEPATITIS C, CHRONIC; HUMANS; LIVER TRANSPLANTATION; LIVING DONORS; RECURRENCE; RISK FACTORS; ROMANIA; TISSUE AND ORGAN PROCUREMENT; TRANSPLANTATION IMMUNOLOGY;

EID: 11844273819     PISSN: 12214167     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (89)

1. Wiesner RH, Rakela J, Ishitani MB, et al. Recent advances in liver transplantation. Mayo Clin Proc 2003; 78: 197-210
2. Ratcliffe J, Longworth L, Young T, et al. Cost-effectiveness of Liver Transplantation Team. Assessing health-related quality of life pre- and post-liver transplantation: a prospective multicenter study. Liver Transpl 2002; 8: 263-270
3. 2001 OPTN/SRTR Annual Report 1991-2000. HHS/HRSA/ OSP/DOT; UNOS; URREA (www.ustransplant.org)
4. Popescu I, Ionescu M, Ciurca S et al. Analysis of an East-European experience in liver transplantation - difficulties and perspectives. ROMTRANSPLANT Congress 2004: 96-97 (abstr.)
5. National Institute of Biostatistics. Romanian Statistical Yearbook 2003, Bucharest
6. Gheorghe L, Iacob S, Iacob R, et al. Predictors of death on the waiting list for liver transplantation in Romania. Gut 2003; 52 (Suppl 6): A160
7. Zota V, Popescu I, Ciurca S, et al. Successful use of the liver of a methanol poisoned brain death organ donor. Transpl Int 2003; 16: 444-446
8. Popescu I, Simionescu M, Tulbure D, et al. Homozygous familial hypercholesterolemia: specific indication for domino liver transplantation. Transplantation 2003; 76: 1345-1350
9. Raia S, Nery JR, Mies S. Liver transplantation from live donors. Lancet 1989; 2: 497
10. Strong RW, Lynch SV, Ong TH, et al. Successful liver transplantation from a living donor to her son. N Engl J Med 1990; 322: 1505-1507
11. Reding R, de Goyet J, Delbeke I, et al. Pediatric liver transplantation with cadaveric or living related donors: comparative results in 90 elective recipients of primary grafts. J Pediatr 1999; 134: 280-286
12. Yamaoka Y, Washida M, Honda K, et al. Liver transplantation using a right lobe graft from a living related donor. Transplantation 1994; 57: 1127-1130
13. Wachs ME, Bak TE, Karrer FM, et al. Adult living donor liver transplantation using a right hepatic lobe. Transplantation 1998; 66: 1313-1316
14. Trotter JF, Wachs M, Everson GT, et al. Adult-to-adult transplantation of the right hepatic lobe from a living donor. N Engl J Med 2002; 346: 1074-1082
15. Testa G, Malago M, Nadalin S, et al. Right-liver living donor transplantation for decompensated end-stage liver disease. Liver Transpl 2002; 8: 340-346
16. Todo S, Furukawa H, Jin MB, et al. Living donor liver transplantation in adults: outcomes in Japan. Liver Transpl 2000; 6 (Suppl 2): S66-S72
17. Broelsch CE, Malago M, Testa G, et al. Living donor liver transplantation in adults: outcomes in Europe. Liver Transpl 2000; 6 (Suppl 2): S64-S65
18. Trotter JF, MacKenzie S, Wachs M, et al. Comprehensive cost comparison of adult-adult right hepatic lobe living-donor liver transplantation with cadaveric transplantation. Transplantation 2003; 75: 473-476
19. Shiffman ML, Brown RS Jr, Olthoff KM, et al. Living donor liver transplantation: summary of a conference at The National Institutes of Health. Liver Transpl 2002; 8: 174-188
20. Beavers KL, Sandler RS, Shrestha R. Donor morbidity associated with right lobectomy for living donor liver transplantation to adult recipients: a systematic review. Liver Transpl 2002; 8: 110-117
21. Davis GL. Chronic hepatitis C and liver transplantation. Rev Gastroenterol Disord 2004; 4: 7-17
22. Wong JB, McQuillan GM, McHutchinson JG, Poynard T. Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health 2000; 90: 1562-1569
23. Vargas HE, Laskus T, Wang LF, et al. The influence of hepatitis C virus genotypes on the outcome of liver transplantation. Liver Transpl Surg 1998; 4: 22-27
24. Ghobrial RM, Steadman R, Gornbein J, et al. A 10-years experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients. Ann Surg 2001; 234: 384-394
25. Charlton M, Seaberg E, Wiesner R, et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 1998; 28: 823-830
26. Prieto M, Berenguer M, Rayon JM, et al. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: Relationship with rejection episodes. Hepatology 1999; 29: 250-256
27. Charlton M. Natural history of hepatitis C and outcomes following liver transplantation. Clin Liver Dis 2003; 7: 585-602
28. Forman LM, Lewis DJ, Berlin JA, et al. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002; 122: 889-896
29. Rodriguez-Luna H, Vargas HE, Sharma P, et al. Hepatitis C virus recurrence in living donor liver transplant recipients. Dig Dis Sci 2004; 49: 38-41
30. Baltz AC, Trotter JF. Living donor liver transplantation and hepatitis C. Clin Liver Dis 2003; 7: 651-665
31. Inomata Y, Tanaka K, Uemoto S, et al. Living donor liver transplantation: an 8-year experience with 379 consecutive cases. Transplant Proc 1999; 31: 381-386
32. Ghobrial RM, Saab S, Lassman C, et al. Donor and recipient outcomes in right lobe adult living donor liver transplantation. Liver Transpl 2002; 8: 901-909
33. Forman LM, Trotter JF, Emond J. Living donor liver transplantation and hepatitis C. Liver Transpl 2004; 10: 347-348
34. Shaked A. Living donor transplantation: recipient outcomes. Annual Meeting of the American Transplant Congress, Washington D.C, 2003
35. Gaglio PJ, Malireddy S, Russo M, et al. Hepatitis C recurrence in recipients of grafts from living vs. cadaveric liver donors (abstr.). Hepatology 2002; 36: 265A
36. Ghobrial RM, Amherst F, Farmer DG, et al. Rapid and severe early HCV recurrence following adult living donor liver transplantation (abstr.). Am J Transplant 2002; 2 (suppl 3): 163A
37. Trotter J, Schiano T, Kim-Schluger L, et al. Living donor liver transplantation in hepatitis C patients: short-term results compared to cadaveric transplantation. Am J Transplant 2001: 1 (suppl): 316A
38. Taniguchi MWM, Wachs M, Bak T, Trotter J, et al. Hepatitis C recurrence in living donor liver transplantation. Am J Transplant 2002; 2 (suppl 3): 138A (abstr.)
39. Shiffman ML, Fisher RA, Stravitz RT, et al. Histologic analysis of recurrent hepatitis C virus infection following living donor and cadaveric liver transplantation (abstr.). Am J Transplant 2003; 3 (suppl 5): 203
40. Russo MW, Galanko J, Beavers K, et al. Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United States. Liver Transpl 2004; 10: 340-346
41. Guerrero RB, Batts KP, Burgart LJ, et al. Early detection of hepatitis C allograft reinfection after orthotopic liver transplantation: a molecular and histologic study. Mod Pathol 2000; 13: 229-237
42. Garcia-Retortillo M, Forns X, Feliu A, et al. Hepatitis C virus kinetics during and immeiately after liver transplantation. Hepatology 2002; 35: 680-687
43. Berenguer M, Ferrell L, Watson J, et al. HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol 2000; 32: 673-684
44. Schluger LK, Sheiner PA, Thung SN, et al. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology 1996; 23: 971-976
45. Sreckumar R, Gonzales-Koch A, Maor-Kendler Y, et al. Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation. Hepatology 2000; 32: 1125-1130
46. Gordon FD, Poterucha JJ, Germer J, et al. Relationship between hepatitis C genotype and severity of recurrent hepatitis C after liver transplantation. Transplantation 1997; 63: 1419-1423
47. Sanchez-Fueyo A, Gimenez-Barcons M, Puig-Basagoiti F, et al. Influence of the dynamics of the hypervariable region 1 of hepatitis C virus (HCV) on the histological severity of HCV recurrence after liver transplantation. J Med Virol 2001; 65: 266-275
48. Farci P, Shimoda A, Coiana A, et al. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 2000; 288: 339-344
49. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001; 345: 41-52
50. Feray C, Gigou M, Samuel D, et al. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 1995; 108: 1088-1096
51. Gane EJ, Naoumov NV, Qian K, et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 1996; 110: 167-177
52. Gane EJ, Portmann BC, Naoumov NV, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996; 334: 815-820
53. Gayowski T, Singh N, Marino IR, et al. Hepatitis C virus genotypes in liver transplant recipients. Transplantation 1997; 64: 422-426
54. Zhou S, Therrault NA, Farrell L, et al. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. Hepatology 1996; 24: 1041-1046
55. Feray C, Caccamo L, Alexander GJ, et al. European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. Gastroenterology 1999; 117: 619-625
56. Pelletier SJ, Raymond DP, Crabtree TD, et al. Pretransplantation hepatitis C virus quasispecies may be predictive of outcome after liver transplantation. Hepatology 2000; 32: 375-381
57. Nair S, Eustace J, Thuluvath PJ. Effect of race on outcome of orthotopic liver transplantation: a cohort study. Lancet 2002; 359: 287-293
58. Rosen HR, Hinrichs DJ, Gretch DR, et al. Association of multispecific CD4+ response to hepatitis C and severity of recurrence after liver transplantation. Gastroenterology 1999; 117: 926-932
59. Belli LS, Zavaglia C, Alberti AB, et al. Influence of immunogenetic background on the outcome of recurrent hepatitis C after liver transplantation. Hepatology 2000; 31: 1345-1350
60. Porter SB, Reddy KR. Factors that influence the severity of recurrent hepatitis C virus following liver transplantation. Clin Liver Dis 2003; 7: 603-614
61. Wali M, Harrison RF, Gow PJ, Mutimer D. Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C. Gut 2002; 51: 248-252
62. Machicao VI, Krishna M, Bonatti H, et al. Hepatitis C recurrence is not associated with allograft steatosis within the first year after liver transplantation. Liver Transpl 2004; 10: 599-606
63. Baron PW, Sindram D, Higdon D, et al. Prolonged rewarming time during allograft implantation predisposes to recurrent hepatitis C infection after liver transplantation. Liver Transpl 2000; 6: 407-412
64. Charlton M, Seaberg E. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institutes of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Liver Transpl & Surgery 1999; 5 (suppl 14): 107-114
65. Sheiner PA, Schwartz ME, Mo E, et al. Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology 1995; 21: 30-34
66. Rosen HR, Shackleton CR, Higa L, et al. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation. Am J Gastroenterol 1997; 92: 1453-1457
67. Burak KW, Kremers WK, Batts KP, et al. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C. Liver Transpl 2002; 8: 362-269
68. Razonable RR, Burak KW, van Cruijsen H, et al. The pathogenesis of hepatitis C virus is influenced by cytomegalovirus. Clin Infect Dis 2002; 35: 974-981
69. Rosen HR, Chou S, Corless CL, et al. Cytomegalovirus viremia: risk factor for allograft cirrhosis after liver transplantation for hepatitis C. Transplantation 1997; 64: 721-726
70. Bocchetta M, Bruscalupi G, Castellano F, et al. early induction of LDL receptor gene during rat liver regeneration. J Cell Physiol 1993; 156: 601-609
71. Agnello V, Abel G, Elfahal M, et al. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci USA 1999; 37: 12766-12771
72. Honda M, Kaneko S, Matsushita E, et al. Cell cycle regulation of hepatitis C virus internal ribosomal entry site-directed translation. Gastroenterology 2000; 118: 152-162
73. Wright T, Coombs C, Kim M, et al. Interferon-α therapy for hepatitis C virus infection after liver transplantation. Hepatology 1994; 20: 773-779
74. Gane EJ, Lo SK, Riordan SM, et al. A randomised study comparing ribavirin and interferon-α monotherapy for hepatitis C recurrence after liver transplantation. Hepatology 1998; 27: 1403-1407
75. Samuel D, Bizollon T, Feray C, et al. Interferon-α 2b plus Ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study. Gastroenterology 2003; 124: 642-650
76. Ahmad J, Dodson S, Demetris A, et al. Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa plus ribavirin. Liver Transpl 2001; 7: 863-869
77. Alberti AB, Belli LS, Airoldi A, et al. Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: A pragmatic study. Liver Transpl 2001; 7: 870-876
78. De Vera ME, Smallwood GA, Rosado K, et al. Interferon alfa and ribavirin for treatment of recurrent hepatitis C after liver transplantation. Transplantation 2001; 71: 678-686
79. Nair S, Khan S, Loss G, et al. Treatment of recurrent hepatitis C virus in liver transplant recipients: is there any histologic benefit? Liver Transpl 2003; 9: 354-359
80. Bizollon T, Ahmed SN, Radenne S, et al. Long term histological improvement and clearance of HCV RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence. Gut 2003; 52: 283-287
81. Firpi RJ, Abdelmalek MF, Soldevila-Pico C, et al. Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent HCV. Liver Transpl 2002; 8: 1000-1006
82. Shakil AO, McGuire B, Crippin J, et al. A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C virus. Hepatology 2002; 36: 1253-1258
83. Lavezzo B, Franchello A, Smedile A, et al. Treatment of recurrent HCV in liver transplants: efficacy of a six versus a twelve months course of interferon alfa 2b with ribavirin. J Hepatol 2002; 37: 247-252
84. Narayanan Menon KV, Poterucha JJ, El-Amin OM, et al. Treatment of posttransplant recurrence of HCV with interferon and ribavirin: lessons on tolerability and efficacy. Liver Transpl 2002; 8: 623-629
85. Gane E. Treatment of recurrent HCV. Liver Transpl 2002; 8: S28-S37
86. Forns X, Garcia-Retortillo M, Serrano T, et al. Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation. J Hepatol 2003; 39: 389-396
87. Terrault NA. Prophylactic and preemptive therapies for hepatitis C virus infected patients undergoing liver transplantation. Liver Transpl 2003; 9: S95-S100
88. Dumortier J, Scoazec J-Y, Chevallier P, et al. Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combination. J Hepatol 2004; 40: 669-674
89. Halprin A, Trotter JF, Everson GT, et al. Post-transplant erradication of hepatitis C by pre-transplant treatment in living donor liver transplant recipients. Hepatology 2001; 34: 244A